USE OF 2-METHYLENE-19-NOR-(20S)-1A,25-DIHYDROXYVITAMIN D3 TO TREAT PRIMARY HYPERPARATHYROIDISM

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15817706.3

公开号：

EP3240548A1

申请日:

2015.12.11

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

Disclosed are methods of administering 2-methylene-19-nor-(20S)-1&alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism and/or to treat and/or prevent the symptoms of primary hyperparathyroidism in as subject having or at risk for developing primary hyperparathyroidism, preferably without inducing hypercalcemia in the patient

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/